Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 23;18(1):2533258.
doi: 10.1080/20523211.2025.2533258. eCollection 2025.

Prevalence, patterns, drivers, and perceived benefits of herbal medicine use in COVID-19 patients in Qatar

Raneem Alsheikh  1 , Fatima R Alsharif  1 , Nouran Alwisi  1 , Zachariah Nazar  2 , Mohamed Ahmed Syed  3 , Hamda Abdulla Qotba  3 , Layla Al-Mansoori  4   5 , Zumin Shi  6 , Abdullah A Shaito  1   4   5
Affiliations

Prevalence, patterns, drivers, and perceived benefits of herbal medicine use in COVID-19 patients in Qatar

Raneem Alsheikh et al. J Pharm Policy Pract. .

Abstract

Background: Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged as a global health crisis in early 2020, leading to widespread morbidity and mortality. In Qatar, as of December 2024, the disease burden has reached over 500,000 cases and more than 600 deaths. While conventional treatments have evolved throughout the pandemic, the use of Complementary and Alternative Medicine (CAM), particularly herbal medicine, has also become prevalent. This study investigated the prevalence, reasons, uses, types, self-reported benefits, and sociodemographic determinants of utilising herbal medicine among COVID-19 patients in Qatar.

Methods: A cross-sectional study was conducted among patients attending Qatar Primary Health Care Corporation (PHCC) clinics. Of the 10,000 SMS invitations that were sent, 882 survey responses were received from patients diagnosed with COVID-19 between 1 March 2020, and 30th April 2022. Following the exclusion of 31 participants due to missing data, sociodemographic data from 851 participants were analysed using logistic regression to assess predictors of herbal medicine use. Prevalence, patterns, types, and self-reported benefits were analysed using descriptive statistics.

Results: Of the 851 respondents included in the analysis, 440 (51.7%) reported herbal medicine use. Herbal medicine use was associated with better-perceived health outcomes. Women were more likely to use herbal medicine than men (OR = 1.90, 95%CI: 1.30-2.77, p = 0.001). The most used herbal remedies were ginger (n = 347), turmeric (n = 207), and garlic (n = 155). Family tradition (42%), the belief that herbs are natural (34.8%), and the desire to improve health and survival (31.1%) were the leading drivers of herbal medicine use.

Conclusion: Herbal medicine use was prevalent (51.7%) during COVID-19 in Qatar, with a higher prevalence of use among women. This prevalence was driven by cultural beliefs and perceived health benefits. The study contributes insights to guide future research, policy, and practice toward safe and evidence-informed integration of herbal medicine in pandemic preparedness and broader healthcare strategies.

Keywords: CAM; COVID-19; Qatar; ginger; herbal medicine; self-prescription; turmeric.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported by the author(s).

Figures

Figure 1.
Figure 1.
Forms of herbal remedies used by COVID-19 patients in Qatar. Bar labels denote the responses received for a herbal medicine form. The frequency of responses is reported as the number of responders divided by the number of respondents. Participants were allowed to choose multiple options when asked about the form of herbs they use.
Figure 2.
Figure 2.
Frequency of use of herbal remedies by COVID-19 patients in Qatar. Bar labels denote the responses received for a herbal medicine type. The frequency of responses is reported as the number of responders divided by the number of respondents. Respondents were allowed to give multiple responses when asked about the herbs they use.
See this image and copyright information in PMC

Similar articles

  • Sexual Harassment and Prevention Training.
    Cedeno R, Bohlen J. Cedeno R, et al. 2024 Mar 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Mar 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 36508513 Free Books & Documents.
  • Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J, Sharma P, Berhane S, van Wyk SS, Nyaaba N, Domen J, Taylor M, Cunningham J, Davenport C, Dittrich S, Emperador D, Hooft L, Leeflang MM, McInnes MD, Spijker R, Verbakel JY, Takwoingi Y, Taylor-Phillips S, Van den Bruel A, Deeks JJ; Cochrane COVID-19 Diagnostic Test Accuracy Group. Dinnes J, et al. Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3. Cochrane Database Syst Rev. 2022. PMID: 35866452 Free PMC article.
  • Herbal and dietary therapies for primary and secondary dysmenorrhoea.
    Proctor ML, Murphy PA. Proctor ML, et al. Cochrane Database Syst Rev. 2001;(3):CD002124. doi: 10.1002/14651858.CD002124. Cochrane Database Syst Rev. 2001. Update in: Cochrane Database Syst Rev. 2016 Mar 22;3:CD002124. doi: 10.1002/14651858.CD002124.pub2. PMID: 11687013 Updated.
  • The effect of sample site and collection procedure on identification of SARS-CoV-2 infection.
    Davenport C, Arevalo-Rodriguez I, Mateos-Haro M, Berhane S, Dinnes J, Spijker R, Buitrago-Garcia D, Ciapponi A, Takwoingi Y, Deeks JJ, Emperador D, Leeflang MMG, Van den Bruel A; Cochrane COVID-19 Diagnostic Test Accuracy Group. Davenport C, et al. Cochrane Database Syst Rev. 2024 Dec 16;12(12):CD014780. doi: 10.1002/14651858.CD014780. Cochrane Database Syst Rev. 2024. PMID: 39679851 Free PMC article.
  • Antibody tests for identification of current and past infection with SARS-CoV-2.
    Fox T, Geppert J, Dinnes J, Scandrett K, Bigio J, Sulis G, Hettiarachchi D, Mathangasinghe Y, Weeratunga P, Wickramasinghe D, Bergman H, Buckley BS, Probyn K, Sguassero Y, Davenport C, Cunningham J, Dittrich S, Emperador D, Hooft L, Leeflang MM, McInnes MD, Spijker R, Struyf T, Van den Bruel A, Verbakel JY, Takwoingi Y, Taylor-Phillips S, Deeks JJ; Cochrane COVID-19 Diagnostic Test Accuracy Group. Fox T, et al. Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2. Cochrane Database Syst Rev. 2022. PMID: 36394900 Free PMC article.
See all similar articles

References

    1. Abouelela, R. S., et al. (2025). Utilization of complementary medicine among type 2 diabetes patients in Qatar: A cross sectional study. SSRN. https://ssrn.com/abstract=5143193 or 10.2139/ssrn.5143193. - DOI
    1. Abuelgasim, K. A., Alsharhan, Y., Alenzi, T., Alhazzani, A., Ali, Y. Z., & Jazieh, A. R. (2018). The use of complementary and alternative medicine by patients with cancer: A cross-sectional survey in Saudi Arabia. BMC Complementary and Alternative Medicine, 18(1), 88. 10.1186/s12906-018-2150-8 - DOI - PMC - PubMed
    1. AlBraik, F. A., Rutter, P. M., & Brown, D. (2008). A cross-sectional survey of herbal remedy taking by United Arab Emirate (UAE) citizens in Abu Dhabi. Pharmacoepidemiology and Drug Safety, 17(7), 725–732. 10.1002/pds.1591 - DOI - PubMed
    1. AlMusleh, Z., & Aboushanab, T. (2022). Regulatory status of complementary medicine in Qatar: An update. Integrative Medicine Research, 11(4), 100896. 10.1016/j.imr.2022.100896 - DOI - PMC - PubMed
    1. Alnaimat, F., Alduraidi, H., Alhafez, L., Abu Raddad, L., Haddad, B. I., Hamdan, M., Alajlouni, J., Afifi, F. U., & Almohammed, O. A. (2023). Rates, patterns, and predictors of complementary medicine use among patients with musculoskeletal diseases. PLoS One, 18(6), e0287337. 10.1371/journal.pone.0287337 - DOI - PMC - PubMed

LinkOut - more resources